SANA FY 2022 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$273M

Net Income

-$269M

EPS (Diluted)

$-1.43

Cash Flow

Operating Cash Flow

-$290M

Free Cash Flow

-$311M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$823M

Total Liabilities

$323M

Stockholders' Equity

$499M

Cash & Equivalents

$177M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$273M	-$357M	+23.6%
Net Income	-$269M	-$356M	+24.3%